A transdermal contraceptive device, based on a patent-pending m- TDD system, will be optimized to daily deliver specified dosages of a progestin and an estrogen, at zero-order controlled rate. The device(s) will be assessed for safety, pharmacokinetic profiles, systemic bioavailability and dose proportionality of the drugs delivered. Phase I clinical studies will be completed following appropriate regulatory review and approval.

Project Start
1989-04-01
Project End
1992-12-31
Budget Start
1992-03-01
Budget End
1992-12-31
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Rutgers University
Department
Type
Schools of Pharmacy
DUNS #
038633251
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901